Sage Therapeutics Email Format
Biotechnology Research
・
201-500 employees
・
Cambridge, MA, USA
Sage Therapeutics is a biopharmaceutical company developing novel therapies for debilitating brain disorders, pioneering new pathways to transform how neurological conditions are treated.
Search our verified sources for decision-makers, emails, and titles.
Start searching
VERIFIED BY CLAY
first.last@sagerx.com
Company Overview
Industry
Biotechnology Research
Founded
2010
Headquarters
Cambridge, MA, USA
Revenue
$25M-$50M
FUNDING Stage
Public
Website
Key Executives
Barry Greene (Chief Executive Officer), Christopher Benecchi (Chief Operating Officer)
Tech Stack
Salesforce Marketing Cloud Personalisation
Marketing
Signup
to know
Signup
to know
Signup
to know
Key Executives
4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified
Frequently Asked Questions
What is the email format of Sage Therapeutics?
Sage Therapeutics uses the first.last format, so Jane Smith would be jane.smith@sagerx.com.
What is ZURZUVAE, and what condition does Sage Therapeutics developed it to treat?
ZURZUVAE (zuranolone) is an oral neuroactive steroid and GABA-A receptor positive allosteric modulator that Sage Therapeutics developed and received FDA approval for in August 2023, making it the first and only oral treatment indicated for adults with postpartum depression.
How can I find and verify contact details for Sage Therapeutics employees using a tool like Clay?
You can use Clay to look up Sage Therapeutics employees by name and role, verify their email addresses against the first.last@sagerx.com format, and enrich your prospect list with confirmed contact data before reaching out.
When was Sage Therapeutics acquired by Supernus Pharmaceuticals, and what product did the deal center on?
Supernus Pharmaceuticals completed its acquisition of Sage Therapeutics on July 31, 2025, in a deal valued at up to approximately $795 million, with ZURZUVAE serving as the primary commercial asset that drove the transaction.
Where is Sage Therapeutics headquartered, and what scientific platform underpins its drug development work?
Sage Therapeutics is headquartered in Cambridge, MA, and its drug development is built on targeting the GABA-A receptor system with neuroactive steroid compounds designed to address brain health conditions including depression.
Get access to more people and company data using Clay
Leverage the power of 100+ data providers for industry-leading data coverage & quality.
4.9 rating